Figure 1.
Relapse-free survival curves in 313 patients with breast cancer in terms of ir-NE concentration in tumor extracts. The major statistical endpoint of this study was disease recurrence (distant recurrences only). The cutoff point between high and low enzyme levels is 9.0 µg/100 mg protein. Numbers in parentheses show the total number of patients per group.
